PIGA mutations and glycosylphosphatidylinositol anchor dysregulation in polyposis-associated duodenal tumorigenesis.


Journal

Molecular cancer research : MCR
ISSN: 1557-3125
Titre abrégé: Mol Cancer Res
Pays: United States
ID NLM: 101150042

Informations de publication

Date de publication:
28 Mar 2024
Historique:
accepted: 26 03 2024
received: 05 10 2023
revised: 30 01 2024
medline: 28 3 2024
pubmed: 28 3 2024
entrez: 28 3 2024
Statut: aheadofprint

Résumé

The pathogenesis of duodenal tumours in the inherited tumour syndromes Familial Adenomatous Polyposis (FAP) and MUTYH-associated Polyposis (MAP) is poorly understood. This study aimed to identify genes that are significantly mutated in these tumours and to explore the effects of these mutations. Whole exome and whole transcriptome sequencing identified recurrent somatic coding variants of PIGA in 19/70 (27%) FAP and MAP duodenal adenomas, and further confirmed the established driver roles for APC and KRAS. PIGA catalyses the first step in glycosylphosphatidylinositol (GPI) anchor biosynthesis. Flow cytometry of PIGA-mutant adenoma-derived and CRISPR-edited duodenal organoids confirmed loss of GPI anchors in duodenal epithelial cells and transcriptional profiling of duodenal adenomas revealed transcriptional signatures associated with loss of PIGA. Implications: PIGA somatic mutation in duodenal tumours from patients with FAP and MAP and loss of membrane GPI-anchors may present new opportunities for understanding and intervention in duodenal tumorigenesis.

Identifiants

pubmed: 38546397
pii: 742062
doi: 10.1158/1541-7786.MCR-23-0810
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Elena Meuser (E)

Cardiff University, Cardiff, United Kingdom.

Kyle Chang (K)

The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Angharad Walters (A)

Cardiff University, Cardiff, United Kingdom.

Joanna J Hurley (JJ)

Cardiff University, Cardiff, United Kingdom.

Hannah D West (HD)

Cardiff University, Cardiff, United Kingdom.

Iain Perry (I)

Swansea University, Swansea, United Kingdom.

Matthew Mort (M)

Cardiff University, Cardiff, United Kingdom.

Laura Reyes-Uribe (L)

The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Rebekah Truscott (R)

Cardiff University, Cardiff, United Kingdom.

Nicholas Jones (N)

Swansea University, Swansea, United Kingdom.

Rachel Lawrence (R)

Swansea University, Swansea, United Kingdom.

Gareth Jenkins (G)

University of Swansea, United Kingdom.

Peter Giles (P)

Cardiff University, Cardiff, Wales, United Kingdom.

Sunil Dolwani (S)

Cardiff University, Cardiff, United Kingdom.

Bilal Al-Sarireh (B)

Morriston Hospital, Swansea, United Kingdom.

Neil Hawkes (N)

Cwm Taf University Health Board, United Kingdom.

Emma Short (E)

Swansea Bay University Health Board, United Kingdom.

Geraint T Williams (GT)

Cardiff University, Cardiff, United Kingdom.

Melissa W Taggart (MW)

The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Kim Luetchford (K)

Molecular Devices (United Kingdom), Cardiff, United Kingdom.

Patrick M Lynch (PM)

The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Diantha Terlouw (D)

Leiden University Medical Center, Leiden, Netherlands.

Maartje Nielsen (M)

Leiden University Medical Center, Leiden, Netherlands.

Sarah-Jane Walton (SJ)

St Mark's Hospital, Harrow, United Kingdom.

Andrew Latchford (A)

St Mark's Hospital, London, United Kingdom.

Susan K Clark (SK)

St Mark's Hospital, London, United Kingdom.

Julian R Sampson (JR)

Cardiff University, Cardiff, Wales, United Kingdom.

Eduardo Vilar (E)

The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Laura E Thomas (LE)

Swansea University, Swansea, United Kingdom.

Classifications MeSH